Picture the door opening at 11:23 AM on a Tuesday. A man in a white shirt with a government ID card asks for your Schedule H1 register, your last three months of purchase bills, your pharmacist's registration certificate, and your cold-chain temperature log — all at once. No warning. No grace period. That is what a routine drug inspector visit can look like.
You have roughly 60 seconds before the tone of that inspection shifts from routine to adversarial. If you spend those 60 seconds opening filing cabinet drawers, scrolling through WhatsApp for a scanned licence, or explaining that "the register is somewhere in the back" — the inspector has already started writing.
That first minute is the difference between a clean inspection report and a show-cause notice that costs you months of follow-up, legal fees, and the very real possibility of a licence suspension. This post exists so that minute never catches you off guard again.
---
The Schedule H1 Register Gap That Turns a Routine Visit Into a Notice
Picture an inspector asking for the Schedule H1 register going back 90 days. The physical register exists but has four consecutive days of missing entries from a week when the regular staff was on leave. A gap like that is enough to draw a formal objection under Rule 65 of the Drugs and Cosmetics Rules, which requires every Schedule H1 supply to be recorded in a separate register — prescriber's name and address, patient's name, drug and quantity — kept for three years.
Selling a Schedule H1 drug without a prescription is punishable under Section 27(d) of the Drugs and Cosmetics Act, 1940, with imprisonment of one to two years and a fine of not less than ₹20,000. Inspectors have discretion. What they do not have tolerance for is a register that is visibly incomplete or that cannot be produced immediately.
The underlying problem is structural: a paper register depends entirely on whoever is behind the counter at the moment of dispensing. One busy afternoon, one absent staff member, one "I'll fill it in later" — and the continuity the regulation requires is broken. Many pharmacy owners only discover the gap when someone asks to see the register. If yours is still on paper, at least start from the right columns: the Schedule H1 register format is free to download, and Schedule X supplies need their own register again, with the duplicate-prescription rule explained.
The annual cost is not just the fine itself. It includes the time spent with a lawyer drafting a reply, the follow-up inspections that accompany a formal objection, and — in the worst cases — a suspension of the licence itself.
---
Purchase Bills, GST Records, and the Audit Trail Inspectors Cross-Check
Inspectors can cross-reference your dispensing records against your purchase invoices. If your billing system records a sale of a Schedule H medicine but no corresponding purchase invoice exists in your records for that batch, that discrepancy is exactly what gets noted.
Picture an inspector asking for the purchase invoices behind a specific batch of a Schedule H antibiotic. The invoices exist, but they sit in a folder sorted by supplier name, not by medicine or batch number, and finding them takes a long, awkward search. By then, the inspector may already have noted that the records were not immediately producible.
What a note like that can trigger:
- A letter asking for a written explanation
- A follow-up inspection
- A referral if the explanation is not accepted
The cost of a slow search may not be a fine at all. It can be follow-up inspections, letters drafted with professional help, and months of operating under an open inspection record.
---
Patient Data Exposure During an Inspection Is a New and Underappreciated Risk
Many pharmacy owners focus on the D&C Act checklist during an inspection and do not think about what else is visible. An inspector who walks behind your billing counter can see prescription details, patient names, contact numbers, and purchase history on your screen or printed bills — particularly if your system displays a full transaction log on a shared monitor.
The Digital Personal Data Protection Act 2023 (DPDPA 2023) requires that personal data be collected and stored with a defined purpose and that access be restricted. A pharmacy that stores patient prescription data in a shared Excel file, a WhatsApp group, or an unprotected billing desktop is exposed under DPDPA 2023, which applies alongside the D&C Act rather than instead of it.
This is not a theoretical concern. It is a compliance layer that did not exist five years ago and that much older billing software was not designed to address. The risk is compounded for pharmacies that also dispense to institutional clients or run any kind of loyalty or refill programme, because those systems accumulate more patient-level data than a simple billing register.
---
What a Pharmacy Looks Like When All of This Is Already Solved
The before-state is familiar: paper registers in a drawer, purchase invoices in a folder sorted by supplier, a PDF of the pharmacist's licence saved somewhere in a WhatsApp chat, temperature logs written in a notebook near the refrigerator.
The after-state looks like this (what to aim for in any system):
| Document | Before | After |
|---|
| Schedule H1 register | Physical notebook, entries sometimes missing | Recorded at the point of billing with every Rule 65(3)(h) particular |
| Purchase bill audit trail | Folder by supplier, searchable only by memory | Searchable by medicine name, batch, date, HSN 3004 code |
| Pharmacist licence & certificates | PDF in WhatsApp or email | Pinned in a compliance folder, accessible on any device |
| Temperature log | Handwritten notebook | Digital log with timestamps, exportable as PDF |
| GST purchase-sale reconciliation | Manual or month-end exercise | Real-time, exportable to Tally Prime |
When an inspector walks in, the pharmacist is not opening drawers. The H1 entries are there, each tied to its bill. Batches can be looked up by medicine instead of hunted for by supplier folder. The pharmacist's registration certificate is at hand.
That is what becomes possible when the dispensing system and the compliance record are the same system, not two separate things that someone manually tries to keep in sync.
---
What Nesayo Changes About an Inspection
Here is what Nesayo does, and what it does not. A Schedule H1 sale is logged at billing: the date, medicine, batch, quantity and bill number, with the patient and prescriber names entered on the bill. Which medicines count as H1 comes from rules that recognise H1 salts and from the pharmacy's own classification, backed by a catalogue of 2,54,034 medicines whose schedule data is advisory. The pharmacist does not make a separate decision to start an entry. Nesayo does not record the prescriber's address yet, and it does not print or export the register and has no screen yet that lists the full H1 log (the chat's 'H1 register' command shows the latest entries), so the pharmacist adds the address and keeps the Rule 65(3)(h) register complete in the form the inspector expects.
When the question is about a specific batch, search the medicine on the stock page: every batch you hold is listed with its batch number, quantity and expiry. Every bill line records the batch it was sold from, picked earliest expiry first (FEFO), and a batch whose expiry month has passed is refused at billing.
For pharmacies on the Full plan (₹549 per month as of October 2026; verify current pricing at nesayo.com/pricing), the Stock Sense agent flags medicines likely to run out, the Expiry Guard agent sorts batches approaching expiry into 30, 60 and 90-day groups with a discount or return suggestion, and the Morning Briefing agent surfaces what needs attention before the shutter opens.
On the paid plans, voice billing in Hindi and English (beta) means the entry happens at the counter, at the moment of dispensing — not reconstructed later from memory. Billing is free forever (nesayo.com/pricing, as of October 2026). Paid plans start at ₹249 per month for the Essential plan (as of October 2026). There is no integration with Tally Prime — on the Full plan, Nesayo exports a file that Tally Prime reads, which keeps the two systems independent and your accountant's workflow unchanged.
---
The Choice in Front of You Right Now
If you do nothing after reading this, the next drug inspector visit pharmacy will go the way the last one did — or the way you quietly fear it might go. The Schedule H1 register will be as complete as the busiest day allowed it to be. The purchase invoices will be as findable as the filing system your staff built over time. The 60 seconds will pass the way they always do.
If you spend two minutes today, you can see exactly what your compliance posture looks like before an inspector does.
Go to nesayo.com/demo — a sample pharmacy is pre-loaded, no signup required. Bill a Schedule H1 medicine, look up a batch on the stock page, and see what your counter records would look like if the inspector walked in tomorrow morning.
---
FAQ
Will migrating to Nesayo take weeks, and will I lose my existing billing data?
Migration time depends on your current system and data volume. The Nesayo team moves your medicine master and opening stock across from a CSV or Excel export for you, free. Nothing is deleted from your old system during migration; you can run both in parallel until you are confident, and keep the old records for their retention period. The free billing tier means there is no financial pressure to rush.
What happens if my internet goes down during billing or an inspection?
Nesayo is built as a PWA (Progressive Web App) with an offline billing fallback: bills saved while the connection is down are queued on the device and sync automatically when it is restored. Your records live in the cloud, so for an inspection, keep what you would need to show without internet — your licences and the completed H1 register — where you can reach them offline too.
Can I really trust an AI system to maintain my Schedule H1 register accurately enough for a D&C Act inspection?
The Schedule H1 sales log is not AI-generated — ordinary billing logic writes it at the moment of sale: the date, medicine, batch, quantity and bill number, with the patient and prescriber names entered on the bill. Which medicines count as H1 comes from rules that recognise H1 salts and from the pharmacy's own classification; the 2,54,034-medicine catalogue's schedule data is advisory. Nesayo does not record the prescriber's address yet, so the pharmacist adds it to complete the Rule 65(3)(h) register. The AI agents (Morning Briefing, Stock Sense, etc.) are advisory; they surface information for the pharmacist to act on. The pharmacist remains responsible for what is dispensed and for the completeness of the register.